Clinical and biochemical profile of AKI in patients with COVID 19. A single center experience.
Not Applicable
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhereHealth Condition 2: B338- Other specified viral diseases
- Registration Number
- CTRI/2021/03/032067
- Lead Sponsor
- Departmental Funds Depaartment of Medicine SMCW Lavale Pune
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
a. All adult patients (age more than 18 years)
b. Diagnosed patients with COVID 19 RT-PCR positivity hospitalized in SUHRC and SMCW, Lavale, Pune.
Exclusion Criteria
a. Pediatric age group (age less than 18 years)
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method a. Occurrence of AKI and related complications in patients admitted with COVID 19. <br/ ><br>b. Occurrence of AKI in COVID 19 patients with rise or fall of other parameters of disease activity like, serum ferritin, CRP, LDH, IL 6.Timepoint: a. At base line <br/ ><br>b. At 48 hours <br/ ><br>c. At 7 days <br/ ><br>d. At 15 days
- Secondary Outcome Measures
Name Time Method Occurrence of and severity of complications (dialysis, hypoxia, thromboembolism, death) in COVID 19 patients.Timepoint: 14 days